← Search & browse all drugs
ANTIINFECTIVES FOR SYSTEMIC USE › VACCINES › VIRAL VACCINES › Influenza vaccines
influenza, live attenuated
J07BB03
Forms & Strengths
- Nasal spray
- 0.2 mL per 0.2 mL dose
Adult Dosing
- 1 dose annually
- 0.2 mL intranasally
Pediatric Dosing
- 6-35 months: 0.2 mL intranasally, 2 doses 1-2 months apart in first year, 1 dose annually thereafter
- 3-8 years: 0.2 mL intranasally, 2 doses 1 month apart if previously unvaccinated, 1 dose annually thereafter
- 9 years and older: same as adult dosing
Indications
- Prevention of influenza A and B in individuals 2-49 years old
- Not indicated for individuals 50 years and older
Mechanism of Action
- Stimulates immune response to influenza virus
- Produces antibodies against influenza A and B
- Provides mucosal immunity to help prevent infection
Contraindications
- Hypersensitivity to any component of the vaccine or to previous influenza vaccine
- Severe allergic reaction to eggs or egg products
- Active, febrile respiratory illness
- Known immune deficiency
Adverse Reactions
- Runny nose
- Nasal congestion
- Sore throat
- Cough
- Headache
- Fever
- Myalgias
Drug Interactions
- Do not administer with other live or inactivated intranasal vaccines
- Administer at least 4 weeks after other live or inactivated vaccines
- Immune response may be decreased by immunosuppressive therapies
Curated Content: Needs Vetting Before Put to Clinical Use